Close Menu

Texas Children's Cancer Center

Both studies found that about 40 percent of pediatric cancer patients have mutations with potential clinical significance, either for diagnosis or treatment.

The new Pediatric Center for Personal Cancer Genomics and Therapeutics plans to routinely sequence every new patient that comes into the Texas Children's Cancer Center and hopes eventually to begin sequencing all new pediatric cancer cases in the state of Texas.

BCM has started a new pediatric cancer research center that will use clinical tumor sequencing for research and to develop treatments.

The Doris Duke Charitable Foundation has given a nearly $500,000 grant to the Texas Children's Cancer Center and Baylor to identify glioma-causing genetic mutations.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.